Date(s) - 11/07/2017 - 11/08/2017
Location: Washington, D.C.
This event is bringing together big pharma, big data, and healthcare providers to discuss the scientific, economic, and policy goals towards producing precise and genomic-based medicines. This event will fast-track our momentum into the future paradigm of healthcare by spurring the important discussions to get us there.
Both the scientific and the business challenges will be represented. On the science end, Cell and gene therapies have been at the forefront of precision medicine – treating patients with therapies specific to their disease pathway, such as new immunotherapies for cancer – long before PMI was announced. The future of precision medicine will be tied to the future of these groundbreaking therapies, and the challenges they face in bio-manufacturing and commercialization.